April 24, 2016
What could a TMA Membership mean for you, your practice, and your patients?
Texas’ pain management requirements underwent several important changes by law in the past year. Now, the Texas Medical Board has issued rules clarifying what prescribers must do to comply with those laws. Read More
Per the National Institutes of Health (NIH) COVID-19 Treatment Guidelines, which cites insufficient clinical data, the Texas Medical Association COVID-19 Task Force recommends against using chloroquine or hydroxychloroquine to treat COVID-19, “except in a clinical trial.” Read More
Thanks to Texas Medical Association advocacy, the Texas Medical Boardhas refocused its guidance on when physicians will be required to check the Texas Prescription Monitoring Program (PMP) before prescribing certain medications starting March 1. Read More
More Related Stories
The mental health fallout caused by COVID-19 radiates throughout Texas. In this issue, we look at four of the biggest challenges physicians are responding to as more people say that worry and stress related to coronavirus have negatively impacted their mental health. Plus ... Physicians scramble to adapt to new and evolving policies from health plans, who are adapting as well. As they do, Texas physicians are finding a mixed bag of rules and regulations that can hurt and help patient care.
Read the Latest Issue